{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:55:52Z","timestamp":1781765752135,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010609","name":"Gda\u0144ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["ST-22"],"award-info":[{"award-number":["ST-22"]}],"id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biopha.2022.112757","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:31:41Z","timestamp":1645662701000},"page":"112757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Muscle pain and muscle weakness in COVID19 patients: Cross-talk with statins \u2013 Preliminary results"],"prefix":"10.1016","volume":"148","author":[{"given":"Schetz","family":"Daria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sztormowska-Achranowicz","family":"Katarzyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foerster","family":"Jerzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koci\u0107","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2022.112757_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256899","article-title":"Statins use and COVID-19 outcomes in hospitalized patients","volume":"16","author":"Ayeh","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112757_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.625144","article-title":"Case report: myopathy in critically Ill COVID-19 patients: a consequence of hyperinflammation?","volume":"12","author":"Versace","year":"2021","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2022.112757_bib3","article-title":"Coronavirus disease 2019-induced rhabdomyolysis","volume":"12","author":"Meegada","year":"2020","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.biopha.2022.112757_bib4","article-title":"Fatal rhabdomyolysis in a COVID-19 patient on rosuvastatin","volume":"12","author":"Anklesaria","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2022.112757_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03154-4","article-title":"Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU. A retrospective cohort study","author":"Rodriguez-Nava","year":"2020","journal-title":"Crit. Care\u00a0BioMed. Cent."},{"key":"10.1016\/j.biopha.2022.112757_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00003495-199142010-00005","article-title":"A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia","volume":"42","author":"McTavish","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2022.112757_bib7","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1517\/13543784.9.11.2653","article-title":"NK-104: a novel synthetic HMG-CoA reductase inhibitor","volume":"9","author":"Kajinami","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.biopha.2022.112757_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11883-002-0060-0","article-title":"A general assessment of the safety of HMG CoA reductase inhibitors (statins)","volume":"4","author":"Black","year":"2002","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2022.112757_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2011.07.048","article-title":"Managing the underestimated risk of statin-associated myopathy","volume":"159","author":"Rallidis","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112757_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2022.112757_bib11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"European atherosclerosis society consensus panel. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.112757_bib12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2022.112757_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy \u2013 a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.112757_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachex\u00a0Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.biopha.2022.112757_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.17219\/acem\/129573","article-title":"Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: a systematic literature review","volume":"30","author":"Zubak","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.112757_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/17512433.2020.1734451","article-title":"Statins and muscle pain","volume":"13","author":"Pergolizzi","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112757_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3949\/ccjm.83a.14120","article-title":"Approach to asymptomatic creatine kinase elevation","volume":"83","author":"Moghadam-Kia","year":"2016","journal-title":"Cleve Clin. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2022.112757_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40279-017-0689-z","article-title":"Perspectives on exertional rhabdomyolysis","volume":"47","author":"Rawson","year":"2017","journal-title":"Sports Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.112757_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13054-016-1314-5","article-title":"Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice","volume":"20","author":"Chavez","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2022.112757_bib20","series-title":"Creatine Phosphokinase. StatPearls [Internet]","author":"Aujla","year":"2020"},{"issue":"1","key":"10.1016\/j.biopha.2022.112757_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3810\/PSM.2009.04.1685","article-title":"Exertional rhabdomyolysis and acute kidney injury","volume":"37","author":"Patel","year":"2009","journal-title":"Phys. Sportsmed."},{"issue":"4","key":"10.1016\/j.biopha.2022.112757_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.24920\/003663","article-title":"Three cases of rhabdomyolysis induced by viral infections in children and literature review","volume":"35","author":"Ju","year":"2020","journal-title":"Chin. Med. Sci. J."},{"issue":"7","key":"10.1016\/j.biopha.2022.112757_bib23","first-page":"423","article-title":"Statins and muscle pain","volume":"153","author":"Yosef","year":"2014","journal-title":"Harefuah"},{"issue":"6","key":"10.1016\/j.biopha.2022.112757_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.bor.0000434673.85515.89","article-title":"The spectrum of statin myopathy","volume":"25","author":"Mohassel","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112757_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1592\/phco.30.6.541","article-title":"Statin-associated muscle-related adverse effects: a case series of 354 patients","volume":"30","author":"Cham","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.biopha.2022.112757_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.numecd.2012.04.012","article-title":"Discontinuation of statin therapy due to muscular side effects: a survey in real life","volume":"23","author":"Rosenbaum","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2022.112757_bib27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/2047487314525531","article-title":"What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice","volume":"21","author":"Finegold","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.biopha.2022.112757_bib28","first-page":"53","article-title":"Grip strength. Collection of normative data with community dwelling elders","volume":"15","author":"Horowitz","year":"1997","journal-title":"Phys. Occup. Ther. Geriatr."},{"key":"10.1016\/j.biopha.2022.112757_bib29","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/jgs.17335","article-title":"Hand grip strength before and after SARS-CoV-2 infection in community-dwelling older adults","volume":"69","author":"Del Brutto","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.biopha.2022.112757_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/CMR.00001-08","article-title":"Bacterial, fungal, parasitic, and viral myositis","volume":"21","author":"Crum-Cianflone","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2022.112757_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s15010-004-4003-2","article-title":"Influenza-associated myositis in children","volume":"32","author":"Agyeman","year":"2004","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.biopha.2022.112757_bib32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/S0004-282X2012000500002","article-title":"Influenza A (H1N1) induced-myopathy: an important extrapulmonary complication","volume":"70","author":"Oliveira","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"issue":"8","key":"10.1016\/j.biopha.2022.112757_bib33","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/jcm10081734","article-title":"Increased creatine kinase may predict a worse COVID-19 outcome","volume":"10","author":"Orsucci","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2022.112757_bib34","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00508-021-01845-8","article-title":"The advantages of drug treatment with statins in patients with SARS-CoV- infection","volume":"133","author":"Ferrara","year":"2021","journal-title":"Wien. Klin. Woche"},{"key":"10.1016\/j.biopha.2022.112757_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12012-021-09674-x","article-title":"Plausible positive effects of statins in COVID-19 patient","volume":"21","author":"Vitiello","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112757_bib36","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1212\/WNL.29.6.902","article-title":"Increased serum creatine kinase after exercise: a sex-linked phenomenon","volume":"29","author":"Shumate","year":"1979","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.biopha.2022.112757_bib37","first-page":"249","article-title":"Creatine kinase: race-gender differences in patients hospitalized for suspected myocardial infarction","volume":"82","author":"Cook","year":"1990","journal-title":"J. Natl. Med. Assoc."},{"issue":"6","key":"10.1016\/j.biopha.2022.112757_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179898","article-title":"Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians","volume":"12","author":"Yen","year":"2017","journal-title":"PLoS One"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:30:15Z","timestamp":1781764215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222001457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"alternative-id":["S0753332222001457"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112757","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle pain and muscle weakness in COVID19 patients: Cross-talk with statins \u2013 Preliminary results","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112757"}}